Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer
Max Kates, Ahmed M. Mansour, Donald L. Lamm, Neal Shore, Holly Maulhardt, Alison Wendt, James Verco, Alyson Marin, Karan Dewnani, Shelagh Verco, Gere S. Dizerega
Dive into the research topics of 'Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer'. Together they form a unique fingerprint.